Winship investigators will present at the 63rd American Society of Hematology annual meeting, taking place in Atlanta, December 11-14.
Investigators from Winship Cancer Institute of Emory University (Winship) will present at the 63rd American Society of Hematology annual meeting, taking place in Atlanta, December 11-14.
"We are excited that so many of our hematology investigators at Winship have the opportunity to showcase their innovative research at one of the premier hematology conferences in the world," says Sagar Lonial, MD, FACP, Winship chief medical officer and chair of the Emory Department of Hematology and Medical Oncology.
"This year's ASH meeting is taking place in our city, Atlanta," Says David Frank, MD, PhD, FACP, director of the Division of Hematology in Emory's Department of Hematology and Medical Oncology. "We welcome our colleagues attending from across the country and the world who, alongside Winship researchers, will be presenting the latest advances in the field from benign hematology to malignant hematology, and from laboratory investigations to clinical trials."
Beginning with pre-meeting sessions on December 8, Winship investigators will play leading roles in educational workshops, symposia, and other special programming.
- Lonial, along with Jonathan L. Kaufman, MD, Ajay K. Nooka MD, MPH, FACP, Robert Sidonio, Jr., MD, MSc, and Jean Boudreaux, MD, will participate in four Friday Satellite Symposia.
- Fuad El Rassi, MD, will take part in a media panel focused on the risks for patients with blood disorders during COVID-19.
- Educational programs will feature Kristie A. Blum, MD, Christine Kempton, MD, MSc, and Kirsten Williams, MD.
- Martha Arellano, MD, will discuss recruitment and retention at the Training Program Directors' Workshop.
- Scientific workshops include presentations from David L. Jaye, MD, on the application of artificial intelligence in bone marrow and peripheral blood evaluations, and Curtis J. Henry, PhD, on the impact of interleukin-37 on anti-cancer immunity in aged backgrounds.
Beyond the ASH program, Edmund K. Waller, MD, PhD, will co-chair the 10th annual Bone Marrow Transplant (BMT) Cell Therapy Winter Workshop on December 10, which he has co-led and organized since its inception.
From Saturday through Monday, Winship investigators will present nearly a dozen oral abstracts representing novel research advances with a high potential to impact the field.
On Saturday,
- Lonial will share the results of the dose-expansion phase of the CC-220-MM-001 clinical trial for patients with relapsed/refractory multiple myeloma.
- Manoj Bhasin, PhD, scientific director of Winship’s Bioinformatics and Systems Biology Shared Resource, will showcase Survival Genie, a web portal to facilitate single-cell data, gene-ratio, and cell composition-based survival analyses.
- Pamela Allen, MD, MSc, assistant professor of hematology and medical oncology, will report on frontline treatment with pembrolizumab followed by AVD chemotherapy for patients with classic Hodgkin Lymphoma.
- El Rassi, associate professor of hematology and medical oncology, and director of sickle cell research at the Georgia Comprehensive Sickle Cell Program, participates in a media briefing discussing his research on COVID-19 and sickle cell patients.
On Sunday,
- Claire Pillsbury, doctoral student in the Cancer Biology Graduate Program, will highlight Siglec-15 as a novel immunomodulatory protein and therapeutic target in acute lymphoblastic leukemia.
- William Pilcher, doctoral student in the Department of Biomedical Engineering, will share an innovative approach to characterizing T-cell exhaustion in rapid progressing multiple myeloma.
On Monday,
- Jonathan L. Kaufman, MD, professor of hematology and medical oncology, will present the results of a phase 1/2 study evaluating combination therapies for patients with the t(11;14) multiple myeloma subtype.
- Xu Ji, PhD, assistant professor of pediatrics, will present findings on age-related differences between cardiac surveillance in pediatric blood cancer survivors who received anthracycline-based therapy.
In addition to delivering oral presentations and leading sessions, Winship investigators will present nearly three dozen scientific posters at the ASH annual meeting. Poster presenters include Winship Summer Scholar Research Program alum and high school student Theodora Alese.
